20-37933563-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080607.3(VSTM2L):c.316G>T(p.Ala106Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,459,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080607.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSTM2L | NM_080607.3 | c.316G>T | p.Ala106Ser | missense_variant | 3/4 | ENST00000373461.9 | NP_542174.1 | |
VSTM2L | XM_011528530.2 | c.291+1759G>T | intron_variant | XP_011526832.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSTM2L | ENST00000373461.9 | c.316G>T | p.Ala106Ser | missense_variant | 3/4 | 1 | NM_080607.3 | ENSP00000362560 | P1 | |
VSTM2L | ENST00000373459.4 | c.122-10418G>T | intron_variant | 3 | ENSP00000362558 | |||||
VSTM2L | ENST00000448944.1 | c.291+1759G>T | intron_variant | 3 | ENSP00000406537 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251240Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135856
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1459004Hom.: 0 Cov.: 34 AF XY: 0.00000413 AC XY: 3AN XY: 725850
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2023 | The c.316G>T (p.A106S) alteration is located in exon 3 (coding exon 3) of the VSTM2L gene. This alteration results from a G to T substitution at nucleotide position 316, causing the alanine (A) at amino acid position 106 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at